Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes

Clinical and Experimental Allergy

Volumn 38, Issue 11, 2008, Pages 1760-1768

  Bateman, E A L ^a   Ardern Jones, M R ^a,b   Ogg, G S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Atopic dermatitis; Fel d 1; HLA DPB1*0401; HLA DQ B1*06; T cells; T cells epitope

Indexed keywords

ALLERGEN; EPITOPE; FEL D 1 ALLERGEN; GAMMA INTERFERON; HLA ANTIBODY; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIGEN PRESENTATION; CATS; CD4-POSITIVE T-LYMPHOCYTES; DERMATITIS, ATOPIC; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GLYCOPROTEINS; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS;

EID: 54849410237     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03098.x     Document Type: Article

References (59)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 113 : 651 7.
2. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992 17 : 385 91.
3. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994 30 : 35 9.
4. Herd RM, Tidman MJ, Prescott RJ, Hunter JA. Prevalence of atopic eczema in the community: the Lothian Atopic dermatitis study. Br J Dermatol 1996 135 : 18 9.
5. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics 2001 108 : E33.
6. van Neerven RJ, van de Pol MM, van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg ML. Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994 152 : 4203 10.
7. Counsell CM, Bond JF, Ohman JL Jr., Greenstein JL, Garman RD. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. J Allergy Clin Immunol 1996 98 : 884 94.
8. Haselden BM, Larche M, Meng Q et al. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001 108 : 394 401.
9. Reefer AJ, Carneiro RM, Custis NJ et al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004 172 : 2763 72.
10. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999 189 : 1885 94.
11. Raulf-Heimsoth M, Rozynek P, Bruning T, Rihs HP. Characterization of B- and T-cell responses and HLA-DR4 binding motifs of the latex allergen Hev b 6.01 (prohevein) and its post-transcriptionally formed proteins Hev b 6.02 and Hev b 6.03. Allergy 2004 59 : 724 33.
12. Macaubas C, Wahlstrom J, Galvao da Silva AP et al. Allergen-specific MHC class II tetramer+cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 2006 176 : 5069 77.
13. Seneviratne SL, Jones L, King AS et al. Allergen-specific CD8(+) T cells and atopic disease. J Clin Invest 2002 110 : 1283 91.
14. Yssel H, Johnson KE, Schneider PV et al. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+T cell clones. J Immunol 1992 148 : 738 45.
15. Higgins JA, Thorpe CJ, Hayball JD, O'Hehir RE, Lamb JR. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol 1994 93 : 891 9.
16. Woodfolk JA. T-cell responses to allergen. J Allergy Clin Immunol 2007 119 : 280 94.
17. Haselden BM, Kay AB, Larche M. Peptide-mediated immune responses in specific immunotherapy. Int Arch Allergy Immunol 2000 122 : 229 37.
18. Alexander C, Tarzi M, Larche M, Kay AB. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 2005 60 : 1269 74.
19. Alexander C, Ying S, A BK, Larche M. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon-gamma+T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 2005 35 : 52 8.
20. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002 360 : 47 53.
21. Tarzi M, Klunker S, Texier C et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006 36 : 465 74.
22. Williams HC, Burney PGJ, Pembroke AC, Hay RJ. Validation of the UK diagnostic criteria for atopic dermatitis in a population setting. Br J Dermatol 1996 135 : 12 7.
23. Williams HC, Burney PGJ, Hay RJ et al. The UK working party's diagnostic criteria for atopic dernatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994 131 : 383 96.
24. Pala P, Message SD, Johnston SL, Openshaw PJ. Increased aeroallergen-specific interleukin-4-producing T cells in asthmatic adults. Clin Exp Allergy 2002 32 : 1739 44.
25. Gabrielsson S, Paulie S, Rak S et al. Specific induction of interleukin-4-producing cells in response to in vitro allergen stimulation in atopic individuals. Clin Exp Allergy 1997 27 : 808 15.
26. Meyer-Wentrup F, Burdach S. Efficacy of dendritic cell generation for clinical use: Recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14 1 starting populations. J Hematother Stem Cell Res 2003 12 : 289 99.
27. Felzmann T, Witt V, Wimmer D et al. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy 2003 5 : 391 8.
28. Jones L, Black AP, Malavige GN, Ogg GS. Persistent high frequencies of Varicella-Zoster virus ORF4 protein-specific CD4+T cells after primary infection. J Virol 2006 80 : 9772 8.
29. Kaplan DE, Ikeda F, Li Y et al. Peripheral virus-specific T cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 2008 48 : 903 13.
30. Goonetilleke N, Moore S, Dally L et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus nkara-vectored vaccines expressing HIV-1 gag coupled CD8+T-cell epitopes. J Virol 2006 80 : 4717 28.
31. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000 6 : 337 42.
32. Marsh SGE, Parham P, Barber LD. The HLA FactsBook, 1st edn. San Diego : Academic Press, 2000.
33. Vitale E, Cook S, Sun R et al. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum Mol Genet 2002 11 : 295 300.
34. Ettinger RA, Liu AW, Nepom GT, Kwok WW. β57-asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J Immunol 2000 165 : 3232 8.
35. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004 3 : 104 10.
36. Ettinger RA, Kwok WW. A peptide binding motiff for HLA-DQA1*0102/ DQB1*0602, the class II molecule associated with dominant protection in insulin-dependent diabetes Mellitus. J Immunol 1998 160 : 2365 73.
37. Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 2006 176 : 1988 98.
38. Busson M, Castelli FA, Wang XF et al. Prediction of CD4+T cell epitopes restricted to HLA-DP4 molecules. J Immunol Methods 2006 37 : 144 51.
39. Al-Daccak R, Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P. Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. Hum Immunol 1991 31 : 277 85.
40. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLD-DPB1 disparity in the development of acute graft versus-host disease following unrelated donor marrow transplantation. Blood 1993 81 : 1923 32.
41. Moreau P, Cesbron A. HLA-DP and allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 13 : 675 81.
42. Gaschet JA, Lim A, Liem L et al. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J Clin Invest 1996 98 : 100 7.
43. Petersdorf EW, Gooley T, Malkki M et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Brit J Haematol 2001 112 : 988 94.
44. de Waal L, Yuksel S, Brandenburg AH et al. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein. J Virol 2004 78 : 1775 81.
45. Cohen WM, Pouvelle-Moratille S, Wang XF et al. Scanning the HIV genome for CD4+T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule. J Immunol 2006 176 : 5401 8.
46. Mandic M, Castelli F, Janjic B et al. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+T cells from patients with NY-ESO-1-expressing melanoma. J Immunol 2005 174 : 1751 9.
47. Castelli FA, Buhot C, Sanson A et al. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J Immunol 2002 169 : 6928 34.
48. Aldener-Cannava A, Olerup O. HLA-DPB1 typing by polymerase chain reaction amplification with sequence-specific primers. Tissue antigens 2001 57 : 287 99.
49. Yang J, Huston L, Berger D et al. Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells. J Clin Immunol 2005 25 : 428 36.
50. Charron D, Fauchet R, Albert E et al. Genetic diversity of HLA, functional and medical implication. In : Charron D, ed. XXIIth International Histocompatility Workshop and Conference. Paris : EDK, 1997.
51. van Milligen FJ, van 't Hof W, van den Berg M, Aalberse RC. IgE epitopes on the cat (Felis domesticus) major allergen Fel d 1: a study with overlapping synthetic peptides. J Allergy Clin Immunol 1994 93 : 34 43.
52. Southwood S, Sidney J, Kondo A et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998 160 : 3363 73.
53. Rajnavolgyi E, Nagy N, Thuresson B et al. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes. Int Immunol 2000 12 : 281 93.
54. Diepolder HM, Gerlach JT, Zachoval R et al. Immunodominant CD4+T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997 71 : 6011 9.
55. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994 12 : 227 57.
56. Parronchi P, Macchia D, Piccinni MP et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991 88 : 4538 42.
57. Ardern-Jones MR, Black AP, Bateman EAL, Ogg GS. Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells. Proc Natl Acad Sci USA 2007 104 : 5557 62.
58. Bateman EA, Ardern-Jones MR, Ogg GS. Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+T cells. J Allergy Clin Immunol 2006 118 : 1350 6.
59. Carneiro R, Reefer A, Wilson B et al. T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis. J Invest Dermatol 2004 122 : 927 36.